Patellar Tendinitis Market Research Report - Global Forecast till 2027

Patellar tendinitis market research report: by diagnosis (physical examination, imaging tests) treatment (corticosteroid injection, platelet-rich plasma injection, surgery, medical devices), end user (hospitals & clinics) - Global forecast till 2027

ID: MRFR/LS/3698-HCR | | Region: Global | 100 pages

Market Scenario


Tendons are thick cords that attach the muscles to the bones. Inflammation of these tendons is known as tendinitis. Repetitive movement, injury or diseases conditions are main causes of the tendinitis, with severe pain, swelling or tenderness at the affected area. Use of over-the-counter drugs or pain relievers such as non-steroidal anti-inflammatory drugs (NSAIDs), rest therapy and physical therapy are commonly used treatment measures for this condition. Delayed diagnosis of patellar tendinitis may require a surgery to reduce pain, and improve the movement. Tendinitis is found to be prevalent among athletes or sports players as a result of continuous strain on the tendons due to a rigorous workout, running and other activities. Moreover, patellar tendinitis is an injury to the tendon connecting kneecap (patella). The patellar tendon works with the muscles at the front of the thigh to knee. Patellar tendinitis or tendonitis is also known as jumper's knee and is most common in athletes whose sports involve frequent jumping such as basketball and volleyball. However, even people who don't participate in jumping sports can get patellar tendinitis


Increasing prevalence of sports injury, increasing investment by biotechnology and pharmaceutical industries in R&D, and rising need for the better treatment methods drive the growth of the market. Furthermore, favorable reimbursement policies, increased application and significant investments in the development of new technologies for the treatment of diseases are likely to fuel the market growth during the forecast period. Moreover, increasing geriatric population is boost the market growth. Established market players in the developed countries lead the globalization by pushing new products and services into the developing countries and emerging economies. However, side-effects and higher treatment cost may hinder the market growth during the forecast period.


The global patellar tendinitis market is expected to grow at a CAGR of ~8.1% during the forecast period 2017-2023.


Intended Audience



  • Pharmaceutical and Biotechnological Companies

  • Research and Development (R&D) Companies

  • Ambulatory Care Centers

  • Academic Institutes and Universities

  • Market Research and Consulting Service Providers

  • Potential Investors


Figure: Global Patellar Tendinitis Market, By Region Market Share, 2016 (%) Patellar Tendinitis Market


Sources: Annual reports, Press release, White paper, Company presentation


Segmentations


The global patellar tendinitis market is segmented on the basis of diagnosis, treatment, and end user.


On the basis of the diagnosis, it is segmented into the physical examination, imaging tests, and others. The imaging test is further segmented into X-rays, Ultrasound, and Magnetic resonance imaging (MRI).


The treatment segment is divided into corticosteroid injection, platelet-rich plasma injection, surgery, Medical devices, and others. The medical devices are further segmented into the mechanical band, support tape, pre-cut strips, continuous rolls, and others.


Based on the end user, it is segmented into hospitals & clinics, research laboratories, and others.


Regional Analysis


The Americas dominate the global patellar tendinitis market owing to well-developed technology, increasing patient population for sports injury, high health care spending, and increasing government support for research & development. Furthermore, increased R&D activities and the concentration of major companies have fuelled the growth of the market in this region.  


Europe holds the second position in the global patellar tendinitis market owing to the government support for research & development and availability of funds for research. This is expected to continue to drive the European market over the forecasted period. For instance, developed economies such as Germany and France are increasing investment in the healthcare domain and are focusing more on hospital infrastructure.     


The Asia Pacific is the fastest growing patellar tendinitis market owing to the presence of rapidly developing healthcare technology and high healthcare expenditure. Moreover, increasing patient population in countries like India and South Korea are likely to emerge as the fastest growing market across the globe. Furthermore, increasing demand for quality devices in the healthcare sector is projected to lead the use of advanced equipment, which, in turn, may increase the market growth in this region.   


On the other hand, the Middle East & Africa holds the least share of the market owing to less availability of funds, limited medical facilities, and deprived political conditions in Africa.


Key Players


Some of key the players in the market are Abbott (U.S.), Pfizer (U.S.), AstraZeneca (U.K), Bayer (Germany), Merck & Co. Inc. (Germany), GlaxoSmithKline plc (U.S.), Teva Pharmaceutical Industries (Israel), Boehringer Ingelheim Pharmaceuticals, Inc. (Germany), and others.


Research Methodology Patellar Tendinitis Market 2018


Sources: Annual reports, Press release, White paper, and Company presentation



Table of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Global Patellar Tendinitis Market, by Diagnosis

6.1 Introduction

6.2 Physical Examination

6.2.1 Market Estimates & Forecast, 2020-2027

6.3 Imaging Tests

6.3.1 Market Estimates & Forecast, 2020-2027

6.4 Others

6.4.1 Market Estimates & Forecast, 2020-2027

7. Global Patellar Tendinitis Market, by Treatment

7.1 Introduction

7.2 Surgery

7.2.1 Market Estimates & Forecast, 2020-2027

7.3 Corticosteroid injection

7.3.1 Market Estimates & Forecast, 2020-2027

7.4 Platelet-rich plasma injection

7.4.1 Market Estimates & Forecast, 2020-2027

7.5 Others

7.5.1 Market Estimates & Forecast, 2020-2027

8. Global Patellar Tendinitis Market, by End User

8.1 Introduction

8.2 Hospital & Clinics

8.2.1 Market Estimates & Forecast, 2020-2027

8.3 Research Laboratories

8.3.1 Market Estimates & Forecast, 2020-2027

8.4 Others

8.4.1 Market Estimates & Forecast, 2020-2027

9. Global Patellar Tendinitis Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 U.S.

9.2.1.1 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 U.K.

9.3.1.4 Italy

9.3.1.5 Spain

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia Pacific

9.5 The Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest of the Middle East & Africa

10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

11 Company Profiles

11.1 Abbott

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 Pfizer

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 AstraZeneca

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Bayer

11.4.1 Company Overview

11.4.2 Product/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Merck & Co. Inc

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.6 GlaxoSmithKline plc

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.7 Teva Pharmaceutical Industries

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Others

12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Patellar Tendinitis Industry

13 Appendix

LIST OF TABLES

Table 1 Patellar Tendinitis Industry Synopsis, 2020-2027

Table 2 Global Patellar Tendinitis Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 Global Patellar Tendinitis Market by Region, 2020-2027, (USD Million)

Table 4 Global Patellar Tendinitis Market by Diagnosis, 2020-2027, (USD Million)

Table 5 Global Patellar Tendinitis Market by Treatment, 2020-2027, (USD Million)

Table 6 Global Patellar Tendinitis Market by End Users, 2020-2027, (USD Million)

Table 7 North America Patellar Tendinitis Market by Diagnosis, 2020-2027, (USD Million)

Table 8 North America Patellar Tendinitis Market by Treatment, 2020-2027, (USD Million)

Table 9 North America Patellar Tendinitis Market by End Users, 2020-2027, (USD Million)

Table 10 U.S. Patellar Tendinitis Market by Diagnosis, 2020-2027, (USD Million)

Table 11 US Patellar Tendinitis Market by Treatment, 2020-2027, (USD Million)

Table 12 US Patellar Tendinitis Market by End Users, 2020-2027, (USD Million)

Table 13 Canada Patellar Tendinitis Market by Diagnosis, 2020-2027, (USD Million)

Table 14 Canada Patellar Tendinitis Market by Treatment, 2020-2027, (USD Million)

Table 15 Canada Patellar Tendinitis Market by End Users, 2020-2027, (USD Million)

Table 16 South America Patellar Tendinitis Market by Diagnosis, 2020-2027, (USD Million)

Table 17 South America Patellar Tendinitis Market by Treatment, 2020-2027, (USD Million)

Table 18 South America Patellar Tendinitis Market by End Users, 2020-2027, (USD Million)

Table 19 Europe Patellar Tendinitis Market by Diagnosis, 2020-2027, (USD Million)

Table 20 Europe Patellar Tendinitis Market by Treatment, 2020-2027, (USD Million)

Table 21 Europe Patellar Tendinitis Market by End Users, 2020-2027, (USD Million)

Table 22 Western Europe Patellar Tendinitis Market by Diagnosis, 2020-2027, (USD Million)

Table 23 Western Europe Patellar Tendinitis Market by Treatment, 2020-2027, (USD Million)

Table 24 Western Europe Patellar Tendinitis Market by End Users, 2020-2027, (USD Million)

Table 25 Eastern Europe Patellar Tendinitis Market by Diagnosis, 2020-2027, (USD Million)

Table 26 Eastern Europe Patellar Tendinitis Market by Treatment, 2020-2027, (USD Million)

Table 27 Eastern Europe Patellar Tendinitis Market by End Users, 2020-2027, (USD Million)

Table 28 Asia Pacific Patellar Tendinitis Market by Diagnosis, 2020-2027, (USD Million)

Table 29 Asia Pacific Patellar Tendinitis Market by Treatment, 2020-2027, (USD Million)

Table 30 Asia Pacific Patellar Tendinitis Market by End Users, 2020-2027, (USD Million)

Table 31 Middle East & Africa Patellar Tendinitis Market by Diagnosis, 2020-2027, (USD Million)

Table 32 Middle East & Africa Patellar Tendinitis Market by Treatment, 2020-2027, (USD Million)

Table 33 Middle East & Africa Patellar Tendinitis Market by End Users, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Patellar Tendinitis Market

Figure 3 Segmentation Market Dynamics for Patellar Tendinitis Market

Figure 4 Global Patellar Tendinitis Market Share, by Diagnosis 2020

Figure 5 Global Patellar Tendinitis Market Share, by Treatment 2020

Figure 6 Global Patellar Tendinitis Market Share, by End Users, 2020

Figure 7 Global Patellar Tendinitis Market Share, by Region, 2020

Figure 8 North America Patellar Tendinitis Market Share, by Country, 2020

Figure 9 Europe Patellar Tendinitis Market Share, by Country, 2020

Figure 10 Asia Pacific Patellar Tendinitis Market Share, by Country, 2020

Figure 11 Middle East & Africa Patellar Tendinitis Market Share, by Country, 2020

Figure 12 Global Patellar Tendinitis Market: Company Share Analysis, 2020 (%)

Figure 13 Abbott: Key Financials

Figure 14 Abbott: Segmental Revenue

Figure 16 Abbott: Geographical Revenue

Figure 17 Pfizer. Key Financials

Figure 18 Pfizer. Segmental Revenue

Figure 19 Pfizer. Geographical Revenue

Figure 20 AstraZeneca. Key Financials

Figure 21 AstraZeneca. Segmental Revenue

Figure 22 AstraZeneca: Geographical Revenue

Figure 23 Bayer: Key Financials

Figure 24 Bayer: Segmental Revenue

Figure 25 Bayer: Geographical Revenue

Figure 26 Merck & Co. Inc: Key Financials

Figure 27 Merck & Co. Inc: Segmental Revenue

Figure 28 Merck & Co. Inc: Geographical Revenue

Figure 29 GlaxoSmithKline plc: Key Financials

Figure 30 GlaxoSmithKline plc: Segmental Revenue

Figure 31 GlaxoSmithKline plc: Geographical Revenue